Search PDMR transactions

Notifier
Name of person with notification obligation
OT Pharmaceuticals AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Fredrik Lehmann
Position
Member of the Board of Directors
Initial notification
No
Amendment
Yes
Details of amendment
Ändring av anmälningsskyldig till mitt eget bolag
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Sprint Bioscience AB
Issuer´s LEI code
5493006ED74WIIQOKC56
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Sprint Bioscience AB SE0006343745 Acquisition 20,000 Quantity 2.10 SEK 21/11/2023 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Sprint Bioscience AB SE0006343745 Acquisition 21/11/2023 FIRST NORTH SWEDEN 20,000 (Quantity) 2.10 SEK
Total: 20,000
<< Back